Home > News > Alzheimer's intermediate characterised by SS NMR
January 1st, 2008
Alzheimer's intermediate characterised by SS NMR
Abstract:
A team of chemists at the University of Illinois Chicago has characterized the molecular structure of a molecular intermediate in the development of Alzheimer's disease. Using NMR the team has identified a precursor to the misfolded proteins known as plaque-forming amyloid, which is involved in Alzheimer's disease. The same results may also provide clues to understanding and treating Parkinson's and Creutzfeldt-Jakob disease which also involve protein misfolding.
Effective treatment for Alzheimer's remains elusive despite the best efforts of biomedical researchers and drug discovery teams the world over. One of the problems facing drug developers is how to explain the role of amyloid plaques. Whether or not they are a cause or a symptom of the disease is not yet known for sure, although they are certainly a hallmark of this debilitating and lethal disease. Amyloid fibrils are clumps of a fibre-like protein material that is misfolded and is present at nerve cells damaged in this devastating and tragic neurodegenerative diseases.
Now, Yoshitaka Ishii and his colleagues, Sandra Chimon, Medhat Shaibat, Christopher Jones, Diana Calero, and Buzulagu Aizezi, have trapped and characterized a crucial intermediate in the formation of amyloid plaque fibres, or fibrils, showing tiny spheres averaging just twenty nanometres in diameter assembling into sheet-like structures comparable to that seen in the formation of fibrils.
Source:
University of Illinois Chicago
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Molecular Machines
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
A giant step toward miniaturization: Nanotechnology transforms molecular beams into functional nano-devices with controlled atomic architectures April 3rd, 2013
ASU Biodesign Institute scientists develop innovative twists to DNA nanotechnology March 21st, 2013
Reversible assembly leads to tiny encrypted messages March 11th, 2013
Discoveries
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Nanobiotechnology
Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013
Shape of nanoparticles points the way toward more targeted drugs: A collaboration of scientists at Sanford-Burnham and the University of California, Santa Barbara, finds that rod-shaped particles, rather than spherical particles, appear more effective at adhering to cells June 10th, 2013
Catching individual molecules in a million with optical antennas inside nano-boxes June 10th, 2013
Whispering light hears liquids talk: University of Illinois researchers build first-ever bridge between optomechanics and microfluidics June 7th, 2013